Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-8554 in painful diabetic peripheral neuropathy
NCT03172598Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Jul 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of elismetrep in diabetic peripheral neuropathy (DPN) (5 arms), sponsored by Mitsubishi Tanabe Pharma. Primary endpoints: Adverse Events, Vital Signs and 1 more. Started Jul 2017; status: completed.
02
Drugs
elismetrep
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT03172598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03172598.